Related references
Note: Only part of the references are listed.Retrospective Analysis of Cisplatin Nephrotoxicity in Patients With Head and Neck Cancer Receiving Outpatient Treatment With Concurrent High-dose Cisplatin and Radiotherapy
Jennifer Faig et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2018)
Development and Validation of a Risk Prediction Model for Acute Kidney Injury After the First Course of Cisplatin
Shveta S. Motwani et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Guidelines for treatment of renal injury during cancer chemotherapy 2016
Shigeo Horie et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2018)
A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity
Daniel J. Crona et al.
ONCOLOGIST (2017)
Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review
Primoz Strojan et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting
Rudolph M. Navari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin-Based Chemoradiotherapy Regimen for Head and Neck Carcinomas
Jantien Hoek et al.
CANCERS (2016)
Incidence of Cisplatin-Induced Nephrotoxicity and Associated Factors among Cancer Patients in Indonesia
Yenny Prasaja et al.
Asian Pacific Journal of Cancer Prevention (2015)
Understanding the Risk Factors and Long-Term Consequences of Cisplatin-Associated Acute Kidney Injury: An Observational Cohort Study
Zeenat Yousuf Bhat et al.
PLoS One (2015)
Small Acute Increases in Serum Creatinine Are Associated with Decreased Long-Term Survival in the Critically Ill
Adam Linder et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Incidence, Outcomes, and Comparisons across Definitions of AKI in Hospitalized Individuals
Xiaoxi Zeng et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly or Moderately Emetogenic Chemotherapy: A Randomized, Double-Blind, Placebo-Controlled Study
Naomi Mizukami et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2014)
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
Lakhmir S. Chawla et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Raising awareness of acute kidney injury: a global perspective of a silent killer
Andrew J. P. Lewington et al.
KIDNEY INTERNATIONAL (2013)
Comparison of Acute Toxicities in Two Primary Chemoradiation Regimens in the Treatment of Advanced Head and Neck Squamous Cell Carcinoma
Katherine Y. Fan et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Acute kidney injury and chronic kidney disease: an integrated clinical syndrome
Lakhmir S. Chawla et al.
KIDNEY INTERNATIONAL (2012)
Weekly and 3-weekly cisplatin concurrent with intensity-modulated radiotherapy in locally advanced head and neck squamous cell cancer
V. Espeli et al.
ORAL ONCOLOGY (2012)
COMPARISON OF FOUR CISPLATIN-BASED RADIOCHEMOTHERAPY REGIMENS FOR NONMETASTATIC STAGE III/IV SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Dirk Rades et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
Ethan Basch et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference
F. Roila et al.
ANNALS OF ONCOLOGY (2010)
Enhanced renal accumulation of cisplatin via renal organic cation transporter deteriorates acute kidney injury in hypomagnesemic rats
Koji Yokoo et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2009)
American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants
Martee L. Hensley et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
Jean-Pierre Pignon et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: An RTOG analysis
Mitchell Machtay et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Defining risk levels in locally advanced head and neck cancers:: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501)
J Bernier et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2005)
Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer
AA Forastiere et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients
FE de Jongh et al.
BRITISH JOURNAL OF CANCER (2003)
Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer
DJ Adelstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma:: three meta-analyses of updated individual data
JP Pignon et al.
LANCET (2000)
Share Paper
